BioCentury
ARTICLE | Company News

PTC sales and marketing update

December 15, 2014 8:00 AM UTC

PTC launched Translarna ataluren in Germany to treat nonsense mutation Duchenne muscular dystrophy (DMD). The product is a small molecule that facilitates complete translation of proteins containing ...